Order Article Reprints

Guo J, Yang Q, Jiang Q, Gu L-W, Lin H-X, Guo L. Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor. Nutrients. 2023; 15(19):4262. https://doi.org/10.3390/nu15194262

Guo, Jia, Qi Yang, Qi Jiang, Li-Wen Gu, Huan-Xin Lin, and Ling Guo. 2023. "Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor" Nutrients 15, no. 19: 4262. https://doi.org/10.3390/nu15194262

Guo, J., Yang, Q., Jiang, Q., Gu, L.-W., Lin, H.-X., & Guo, L. (2023). Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor. Nutrients, 15(19), 4262. https://doi.org/10.3390/nu15194262